Navigation Links
First Pediatric Patient Treated With Aptocine(TM), a Novel Light-Activated Drug, in Neurofibromatosis Study
Date:8/12/2009

lphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals, and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country, ranking second in National Institutes of Health funding. In addition, its unique family-centered care and public service programs have brought the 430-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu. The Neurofibromatosis (NF) Program is a clinical center for the diagnosis and treatment of neurofibromatosis type 1, providing surveillance and treatment of NF-related problems.

    Contacts
    Light Sciences Oncology, Inc.

    Llew Keltner, M.D., Ph.D.
    President & CEO
    425-957-8940
    dr_llew@lsoncology.com

    Robert M. Littauer
    Vice President,
    Chief Financial Officer
    & Treasurer
    425-957-8946
    bobl@lsoncology.com

    www.lsoncology.com


    The Children's Hospital of Philadelphia (CHOP)

    Rachel Salis-Silverman
    Media Relations Specialist
    267-426-6063
    salis@email.chop.edu

Aptocine(TM), Litx(TM), and Light Infusion Therapy(TM) are trademarks of Light Sciences Oncology, Inc.


'/>"/>
SOURCE Light Sciences Oncology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Jennerex Closes $5 Million First Tranche of Series C Financing
2. William Stanfield, MD, Is First Cleveland-area Orthopedic Surgeon to Perform OtisKnee Custom Fit Knee Replacement
3. Imagenetix, Inc. Reports First Quarter 2010 Results
4. Synthetech Reports First Quarter Fiscal 2010 Results
5. Repligen Reports First Quarter Fiscal Year 2010 Financial Results
6. Nile Therapeutics, Inc. Announces Dosing of First Patient in Phase 2 Study of CD-NP for the Treatment of Acute Heart Failure
7. Hoya Announces First Quarter Financial Results for FY2010
8. Trubion Announces Dates for Second Quarter and First Half 2009 Earnings Conference Call
9. Repligen Announces Conference Call of First Quarter Fiscal Year 2010 Results
10. First genetically engineered malaria vaccine to enter human trials
11. First U.K. Stem Cell Awareness Rally to Take Place in Manchester, England on August 9th, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... THOUSAND OAKS, Calif., Dec. 14 Array ... Inc.(Nasdaq: AMGN ) today announced that they ... rights to Array,s small-molecule glucokinase activator program, including ... clinical trial in patients with Type 2 diabetes. ... agreement, Array will receive an upfront payment of ...
(Date:12/14/2009)... Boston Scientific Corporation (NYSE: BSX ... of $2 billion aggregate principal amount of its senior ... public offering consists of $850 million of 4.50 percent ... notes due January 2020 and $300 million of 7.375 ... to use the net proceeds for general corporate purposes, ...
(Date:12/14/2009)... , - Results From ... Rheumatoid Arthritis in Seven Major Industrialized Countries , , ... arthritis say their disease, impacts ... Women living with rheumatoid arthritis find shopping for gifts, ... wrapping presents most, difficult to ...
(Date:12/11/2009)... Boston College researchers have observed the "hot electron" effect ... successfully harvested the elusive charges using ultra-thin solar cells, ... the authors report in the current online edition of ... captured in solar cells, it generates free electrons in ... snare these charges, the electrons must reach the bottom ...
Breaking Biology Technology:Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4Elusive 'hot' electrons captured in ultra-thin solar cells 2
... (Nasdaq: NVAX ) today announced that it will ... release to be issued after 8:00 a.m. Eastern Time on ... call to discuss its financial results at 10:00 a.m. Eastern ... by Novavax President and Chief Executive Officer Dr. Rahul Singhvi ...
... Company Patents in Each of the Three Critical Areas ... Intradigm Corporation, a leading developer of targeted, systemic RNA ... Patent and Trademark Office (USPTO) has issued the company ... aspects of a potent small interfering RNA (siRNA) sequence. ...
... March 17 Hikma Pharmaceuticals today,announced strong revenue growth ... US Generics business. The weakness in the US was ... Injectable and Branded,businesses. CEO, Said Darwazah, said "The US ... in 2008 we had a loss there so in ...
Other Biology Technology:Novavax Announces Release Date of 2008 Fourth Quarter Financial Results and Investor Conference Call 2Novavax Announces Release Date of 2008 Fourth Quarter Financial Results and Investor Conference Call 3Intradigm Receives Notice of Allowance for Key RNA Interference (RNAi) Patent Covering Potent siRNA Sequence 2
(Date:12/15/2009)... 2009 Economics, environmental impacts, social dynamics, and ... the overall success of an agroecosystem. Positive or ... forcing individuals and social groups to continuously adapt ... , Experiential learning theory suggests that knowledge ... experiences. Such lessons are especially valuable for environmental ...
(Date:12/15/2009)... American researchers found the fossil remains of a whale, 4.5 ... for the first time, the results of the decay and ... cetacean, possibly a baleen whale from the Mysticeti group. , ... remains of a whale from the Lower Pliocene (five million ... is the first time that the results of the processes ...
(Date:12/15/2009)... Group, a leading real-time and embedded technology engineering services ... three high school teams for the 2010 season of ... ). ,, The PTR Group will provide funding to ... The teams from Atholton HS in Columbia, MD, Rockwall ... Vienna, VA all have direct mentorship from engineers in ...
Breaking Biology News(10 mins):Experiential learning teaches change and adaptation 2Story of 4.5 million-year-old whale unveiled in Huelva 2Story of 4.5 million-year-old whale unveiled in Huelva 3The PTR Group Announces Financial and Technical Support to US FIRST Robotics Competition Teams 2Louisiana 26apos 3Bs TCA Cellular Therapy 26apos 3Bs Findings Reported at World Stem Cell Summit Patients 26apos 3B Legs Saved from Amputation Usin 58110 1Louisiana 26apos 3Bs TCA Cellular Therapy 26apos 3Bs Findings Reported at World Stem Cell Summit Patients 26apos 3B Legs Saved from Amputation Usin 58110 2Louisiana 26apos 3Bs TCA Cellular Therapy 26apos 3Bs Findings Reported at World Stem Cell Summit Patients 26apos 3B Legs Saved from Amputation Usin 58110 3Kayentis the Leading Provider of the Unique 26quot 3BPaper Based e Trial 26quot 3B Solution has been Retained for Six New Clinical Studies in the U 58106 1Kayentis the Leading Provider of the Unique 26quot 3BPaper Based e Trial 26quot 3B Solution has been Retained for Six New Clinical Studies in the U 58106 2New stove dramatically improves lung health in Mexican women 58102 1New stove dramatically improves lung health in Mexican women 58102 2New stove dramatically improves lung health in Mexican women 58102 3
... Hopkins have discovered what they believe is the "smoking gun" ... of blood oxygen loss followed by a sudden restoration of ... Hopkins team found that the sudden oxygen bath triggered by ... toxic it kills the cells. The work was published in ...
... in a white lab coat hunched over a microscope ... the scientists who will meet at The American Physiological ... October 8-11 in Virginia Beach, Virginia. , ... animals that hibernate for months without suffering significant muscle ...
... sense of 165-million-year-old dino tracks may be to hang out ... the Red Gulch Dinosaur Tracksite in northern Wyoming. Because they ... have similar feet, emus turn out to be the best ... a long-lost coastline in the Middle Jurassic. , "We don't ...
Other Biology News:Cell death following blood 'reflow' injury tracked to natural toxin 2What animals can tell us about hemorrhage, organ transplants and aging 2What animals can tell us about hemorrhage, organ transplants and aging 3What animals can tell us about hemorrhage, organ transplants and aging 4Trotting with emus to walk with dinosaurs 2Trotting with emus to walk with dinosaurs 3
Ethylene glycol-bis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid, Molecular Biology Grade...
Kit Components: Anti-PARP LumiGLO Chemiluminescent Substrate Immunoblot Blocking Reagent Pyronin Y Reagent Goat Anti-Rabbit IgG, HRP conjugate Double-It Reagent Film Exposure Folders Autor...
Applications: Immunohistochemistry, ISH, FISH, CISH....
Immunogen: Synthetic peptide (KLH conjugated): L(506) S K S S S Q I R M S G L P A D N L A T(525) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: